Myeloid-derived suppressor cells contribute to staphylococcus aureus orthopedic biofilm infection

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3778-3792

  Heim, Cortney E ^a   Vidlak, Debbie ^a   Scherr, Tyler D ^a   Kozel, Jessica A ^a   Holzapfel, Melissa ^a   Muirhead, David E ^a   Kielian, Tammy ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; BIOFILMS; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE; MONOCYTES; MYELOID CELLS; PHENOTYPE; RECEPTORS, CHEMOKINE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTE SUBSETS;

EID: 84898645210     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303408     Document Type: Article

References (72)

1. Zhang, C., G. S. Lei, S. Shao, H. W. Jung, P. J. Durant, and C. H. Lee. 2012. Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infect. Immun. 80: 3634-3641.
2. Serafini, P., I. Borrello, and V. Bronte. 2006. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16: 53-65.
3. Sica, A., and V. Bronte. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117: 1155-1166.
4. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
5. Ochoa, A. C., A. H. Zea, C. Hernandez, and P. C. Rodriguez. 2007. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13: 721s-726s.
6. Sander, L. E., S. D. Sackett, U. Dierssen, N. Beraza, R. P. Linke, M. Müller, J. M. Blander, F. Tacke, and C. Trautwein. 2010. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207: 1453-1464.
7. Delano, M. J., P. O. Scumpia, J. S. Weinstein, D. Coco, S. Nagaraj, K. M. Kelly-Scumpia, K. A. O'Malley, J. L. Wynn, S. Antonenko, S. Z. Al-Quran, et al. 2007. MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204: 1463-1474.
8. Poe, S. L., M. Arora, T. B. Oriss, M. Yarlagadda, K. Isse, A. Khare, D. E. Levy, J. S. Lee, R. K. Mallampalli, Y. R. Chan, et al. 2013. STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol. 6: 189-199.
9. Rieber, N., A. Brand, A. Hector, U. Graepler-Mainka, M. Ost, I. Schäfer, I. Wecker, D. Neri, A. Wirth, L. Mays, et al. 2013. Flagellin induces myeloidderived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J. Immunol. 190: 1276-1284.
10. Obregón-Henao, A., M. Henao-Tamayo, I. M. Orme, and D. J. Ordway. 2013. Gr1intCD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection. PLoS ONE 8: e80669.
11. Wenzel, R. P. 2007. Health care-associated infections: major issues in the early years of the 21st century. Clin. Infect. Dis. 45(Suppl.): S85-S88.
12. Watkins, R. R., M. Z. David, and R. A. Salata. 2012. Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. J. Med. Microbiol. 61: 1179-1193.
13. Osmon, D. R., A. D. Hanssen, and R. Patel. 2005. Prosthetic joint infection: criteria for future definitions. Clin. Orthop. Relat. Res. (437):89-90.
14. Prabhakara, R., J. M. Harro, J. G. Leid, M. Harris, and M. E. Shirtliff. 2011. Murine immune response to a chronic Staphylococcus aureus biofilm infection. Infect. Immun. 79: 1789-1796.
15. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15: 167-193.
16. Thurlow, L. R., M. L. Hanke, T. Fritz, A. Angle, A. Aldrich, S. H. Williams, I. L. Engebretsen, K. W. Bayles, A. R. Horswill, and T. Kielian. 2011. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186: 6585-6596.
17. Ribechini, E., V. Greifenberg, S. Sandwick, and M. B. Lutz. 2010. Subsets, expansion and activation of myeloid-derived suppressor cells. Med. Microbiol. Immunol. (Berl.) 199: 273-281.
18. Condamine, T., and D. I. Gabrilovich. 2011. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32: 19-25.
19. Cuenca, A. G., M. J. Delano, K. M. Kelly-Scumpia, C. Moreno, P. O. Scumpia, D. M. Laface, P. G. Heyworth, P. A. Efron, and L. L. Moldawer. 2011. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 17: 281-292.
20. Bernthal, N. M., A. I. Stavrakis, F. Billi, J. S. Cho, T. J. Kremen, S. I. Simon, A. L. Cheung, G. A. Finerman, J. R. Lieberman, J. S. Adams, and L. S. Miller. 2010. A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS ONE 5: e12580.
21. Hanke, M. L., A. Angle, and T. Kielian. 2012. MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection. PLoS ONE 7: e42476.
22. Herzenberg, L. A., J. Tung, W. A. Moore, L. A. Herzenberg, and D. R. Parks. 2006. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7: 681-685.
23. Hanke, M. L., C. E. Heim, A. Angle, S. D. Sanderson, and T. Kielian. 2013. Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections. J. Immunol. 190: 2159-2168.
24. Hanke, M. L., and T. Kielian. 2012. Deciphering mechanisms of staphylococcal biofilm evasion of host immunity. Front. Cell. Infect. Microbiol. 2: 62.
25. Brudecki, L., D. A. Ferguson, C. E. McCall, and M. El Gazzar. 2012. Myeloidderived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80: 2026-2034.
26. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
27. Haverkamp, J. M., S. A. Crist, B. D. Elzey, C. Cimen, and T. L. Ratliff. 2011. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur. J. Immunol. 41: 749-759.
28. Ioannou, M., T. Alissafi, I. Lazaridis, G. Deraos, J. Matsoukas, A. Gravanis, V. Mastorodemos, A. Plaitakis, A. Sharpe, D. Boumpas, and P. Verginis. 2012. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 188: 1136-1146.
29. Peranzoni, E., S. Zilio, I. Marigo, L. Dolcetti, P. Zanovello, S. Mandruzzato, and V. Bronte. 2010. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22: 238-244.
30. Gabrilovich, D. I., V. Bronte, S. H. Chen, M. P. Colombo, A. Ochoa, S. Ostrand-Rosenberg, and H. Schreiber. 2007. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67: 425.
31. Maenhout, S. K., S. Van Lint, P. U. Emeagi, K. Thielemans, and J. L. Aerts. 2014. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared to their peripheral counterparts. Int. J. Cancer 134: 1077-1090.
32. Lee, P. Y., J. X. Wang, E. Parisini, C. C. Dascher, and P. A. Nigrovic. 2013. Ly6 family proteins in neutrophil biology. J. Leukoc. Biol. 94: 585-594.
33. Prabhakara, R., J. M. Harro, J. G. Leid, A. D. Keegan, M. L. Prior, and M. E. Shirtliff. 2011. Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus. Infect. Immun. 79: 5010-5018.
34. Niska, J. A., J. A. Meganck, J. R. Pribaz, J. H. Shahbazian, E. Lim, N. Zhang, B.W. Rice, A. Akin, R. I. Ramos, N. M. Bernthal, et al. 2012. Monitoring bacterial burden, inflammation and bone damage longitudinally using optical and mCT imaging in an orthopaedic implant infection in mice. PLoS ONE 7: e47397.
35. Archer, N. K., J. M. Harro, and M. E. Shirtliff. 2013. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect. Immun. 81: 2070-2075.
36. Pillay, J., T. Tak, V. M. Kamp, and L. Koenderman. 2013. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell. Mol. Life Sci. 70: 3813-3827.
37. Saiwai, H., H. Kumamaru, Y. Ohkawa, K. Kubota, K. Kobayakawa, H. Yamada, T. Yokomizo, Y. Iwamoto, and S. Okada. 2013. Ly6C+ Ly6G2 myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury. J. Neurochem. 125: 74-88.
38. Rodriguez, P. C., C. P. Hernandez, D. Quiceno, S. M. Dubinett, J. Zabaleta, J. B. Ochoa, J. Gilbert, and A. C. Ochoa. 2005. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 202: 931-939.
39. Xiang, X., A. Poliakov, C. Liu, Y. Liu, Z. B. Deng, J. Wang, Z. Cheng, S. V. Shah, G. J. Wang, L. Zhang, et al. 2009. Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer 124: 2621-2633.
40. Eruslanov, E., I. Daurkin, J. Ortiz, J. Vieweg, and S. Kusmartsev. 2010. Pivotal advance: tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells. J. Leukoc. Biol. 88: 839-848.
41. Wojtasiak, M., D. L. Pickett, M. D. Tate, S. L. Londrigan, S. Bedoui, A. G. Brooks, and P. C. Reading. 2010. Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection. J. Gen. Virol. 91: 2158-2166.
42. Carr, K. D., A. N. Sieve, M. Indramohan, T. J. Break, S. Lee, and R. E. Berg. 2011. Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection. Eur. J. Immunol. 41: 2666-2676.
43. Ribes, S., T. Regen, T. Meister, S. C. Tauber, S. Schütze, A. Mildner, M. Mack, U. K. Hanisch, and R. Nau. 2013. Resistance of the brain to Escherichia coli K1 infection depends on MyD88 signaling and the contribution of neutrophils and monocytes. Infect. Immun. 81: 1810-1819.
44. Serbina, N. V., and E. G. Pamer. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7: 311-317.
45. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
46. Austyn, J. M., and S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11: 805-815.
47. Chandra, D., A. Jahangir, W. Quispe-Tintaya, M. H. Einstein, and C. Gravekamp. 2013. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice. Br. J. Cancer 108: 2281-2290.
48. Zhu, X., J. P. Pribis, P. C. Rodriguez, S. M. Morris, Jr., Y. Vodovotz, T. R. Billiar, and J. B. Ochoa. 2014. The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury. Ann. Surg. 259: 171-178.
49. Rodriguez, P. C., D. G. Quiceno, and A. C. Ochoa. 2007. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109: 1568-1573.
50. Rodriguez, P. C., A. H. Zea, J. DeSalvo, K. S. Culotta, J. Zabaleta, D. G. Quiceno, J. B. Ochoa, and A. C. Ochoa. 2003. L-arginine consumption by macrophages modulates the expression of CD3z chain in T lymphocytes. J. Immunol. 171: 1232-1239.
51. Makarenkova, V. P., V. Bansal, B. M. Matta, L. A. Perez, and J. B. Ochoa. 2006. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176: 2085-2094.
52. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
53. Voyich, J. M., K. R. Braughton, D. E. Sturdevant, A. R. Whitney, B. Saïd-Salim, S. F. Porcella, R. D. Long, D. W. Dorward, D. J. Gardner, B. N. Kreiswirth, et al. 2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175: 3907-3919.
54. Palazzolo-Ballance, A. M., M. L. Reniere, K. R. Braughton, D. E. Sturdevant, M. Otto, B. N. Kreiswirth, E. P. Skaar, and F. R. DeLeo. 2008. Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J. Immunol. 180: 500-509.
55. Cho, J. S., Y. Guo, R. I. Ramos, F. Hebroni, S. B. Plaisier, C. Xuan, J. L. Granick, H. Matsushima, A. Takashima, Y. Iwakura, et al. 2012. Neutrophil-derived IL-1b is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 8: e1003047.
56. Rigby, K. M., and F. R. DeLeo. 2012. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 34: 237-259.
57. Gabrilovich, D. I., M. P. Velders, E. M. Sotomayor, and W. M. Kast. 2001. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166: 5398-5406.
58. Kusmartsev, S., and D. I. Gabrilovich. 2003. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J. Leukoc. Biol. 74: 186-196.
59. Ollivere, B., J. A. Wimhurst, I. M. Clark, and S. T. Donell. 2012. Current concepts in osteolysis. J. Bone Joint Surg. Br. 94: 10-15.
60. Abu-Amer, Y. 2009. Inflammation, cancer, and bone loss. Curr. Opin. Pharmacol. 9: 427-433.
61. Purdue, P. E., P. Koulouvaris, H. G. Potter, B. J. Nestor, and T. P. Sculco. 2007. The cellular and molecular biology of periprosthetic osteolysis. Clin. Orthop. Relat. Res. 454: 251-261.
62. Burton, L., D. Paget, N. B. Binder, K. Bohnert, B. J. Nestor, T. P. Sculco, L. Santambrogio, F. P. Ross, S. R. Goldring, and P. E. Purdue. 2013. Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation. J. Orthop. Res. 31: 73-80.
63. Epstein, N. J., B. A. Warme, J. Spanogle, T. Ma, B. Bragg, R. L. Smith, and S. B. Goodman. 2005. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J. Orthop. Res. 23: 501-510.
64. Shi, S., and X. Zhang. 2012. Interaction of Staphylococcus aureus with osteoblasts. Exp. Ther. Med. 3: 367-370.
65. Cassat, J. E., N. D. Hammer, J. P. Campbell, M. A. Benson, D. S. Perrien, L. N. Mrak, M. S. Smeltzer, V. J. Torres, and E. P. Skaar. 2013. A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe 13: 759-772.
66. Kristian, S. A., T. A. Birkenstock, U. Sauder, D. Mack, F. Götz, and R. Landmann. 2008. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J. Infect. Dis. 197: 1028-1035.
67. Cerca, F., F. Andrade, A. França, E. B. Andrade, A. Ribeiro, A. A. Almeida, N. Cerca, G. Pier, J. Azeredo, and M. Vilanova. 2011. Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages. J. Med. Microbiol. 60: 1717-1724.
68. Schommer, N. N., M. Christner, M. Hentschke, K. Ruckdeschel, M. Aepfelbacher, and H. Rohde. 2011. Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells 774A.1. Infect. Immun. 79: 2267-2276.
69. Spiliopoulou, A. I., F. Kolonitsiou, M. I. Krevvata, M. Leontsinidis, T. S. Wilkinson, D. Mack, and E. D. Anastassiou. 2012. Bacterial adhesion, intracellular survival and cytokine induction upon stimulation of mononuclear cells with planktonic or biofilm phase Staphylococcus epidermidis. FEMS Microbiol. Lett. 330: 56-65.
70. Scherr, T. D., C. M. Roux, M. L. Hanke, A. Angle, P. M. Dunman, and T. Kielian. 2013. Global transcriptome analysis of Staphylococcus aureus biofilms in response to innate immune cells. Infect. Immun. 81: 4363-4376.
71. Günther, F., G. H. Wabnitz, P. Stroh, B. Prior, U. Obst, Y. Samstag, C. Wagner, and G. M. Hänsch. 2009. Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol. Immunol. 46: 1805-1813.
72. Graves, S. F., S. D. Kobayashi, and F. R. DeLeo. 2010. Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence. J. Mol. Med. 88: 109-114.